SCHEMBL13040000

SCHEMBL13040000

Cc1nc(C(=O)N(C)C)c(C)s1

nearest known ligand 0.36

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ MAP4K1 Q92918 2/20 0.36
▸ POLB P06746 3/20 0.35
▸ ALDH1A1 P00352 2/20 0.35
▸ L3MBTL1 Q9Y468 1/20 0.35
▸ PPARD Q03181 1/20 0.33
▸ PPARA Q07869 1/20 0.33
▸ HTR2C P28335 1/20 0.33
▸ CDC7 O00311 1/20 0.33
▸ DBF4 Q9UBU7 1/20 0.33
▸ NPC1 O15118 4/20 0.31
▸ SMN1; SMN2 Q16637 3/20 0.31
▸ LMNA P02545 2/20 0.31
▸ HPGD P15428 1/20 0.31
▸ RAB9A P51151 3/20 0.31
▸ TP53 P04637 1/20 0.31
▸ HTT P42858 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18415695 0.77 L3MBTL1 (0.35) MAP4K1POLBALDH1A1L3MBTL1HTR2C
SCHEMBL17717269 0.76 MAP4K1 (0.35) MAP4K1POLBALDH1A1L3MBTL1NPC1
SCHEMBL17717271 0.76 MAP4K1 (0.35) MAP4K1POLBALDH1A1L3MBTL1NPC1
SCHEMBL2216614 0.76 SMN1; SMN2 (0.40) ALDH1A1PPARDPPARANPC1SMN1; SMN2
SCHEMBL13567165 0.76 HRH3 (0.39) ALDH1A1L3MBTL1PPARDPPARANPC1
SCHEMBL7015920 0.74 PPARD (0.35) ALDH1A1PPARDPPARANPC1SMN1; SMN2
SCHEMBL2305832 0.74 PPARD (0.35) POLBALDH1A1PPARDPPARANPC1
SCHEMBL17717268 0.72 MAP4K1 (0.31) MAP4K1
Hydrochloric Acid SCHEMBL5013627 0.72 PPARD (0.34) ALDH1A1PPARDPPARANPC1SMN1; SMN2
SCHEMBL17717266 0.72 ALDH1A1 (0.44) POLBALDH1A1L3MBTL1CDC7DBF4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9556201-B2 Bicyclic pyridines and analogs as sirtuin modulators GLAXOSMITHKLINE LLC (US) 2017-01-31 — — US disclosed
US-7825155-B2 Oxindole derivative as feeding control agent DAINIPPON SUMITOMO PHARMA CO., LTD. (JP) 2010-11-02 — — US disclosed
US-7825155-B2 Oxindole derivative as feeding control agent DAINIPPON SUMITOMO PHARMA CO., LTD. (JP) 2010-11-02 — — US disclosed
US-20090131398-A1 OXINDOLE DERIVATIVE AS FEEDING CONTROL AGENT DAINIPPON SUMITOMO PHARMA CO., LTD. (JP) 2009-05-21 — — US disclosed
US-20090131398-A1 OXINDOLE DERIVATIVE AS FEEDING CONTROL AGENT DAINIPPON SUMITOMO PHARMA CO., LTD. (JP) 2009-05-21 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090131398-A1 OXINDOLE DERIVATIVE AS FEEDING CONTROL AGENT GPR119, OXTR, CCKAR MAP4K1 3546/4885POLB 4871/4885ALDH1A1 1773/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback